Site Raubling successfully inspected by FDA

PharmaZell GmbH is pleased to announce that its manufacturing site at Raubling, Germany, has successfully passed a FDA inspection in the week of December 5th, 2011 without any FDA form 483 observation. This inspection outcome reconfirms the GMP compliance of Raubling site of last FDA  inspection in 2007.